The Efficacy and Safety of the 1,414 nm Nd:YAG Laser System for Alleviating Back Pain in a Lumbar Disc Patient
A 24-week, Single-center, Open-label, Clinical Study to Evaluate the Efficacy and Safety of the 1,414nm Nd:YAG Laser System Added to PEN to Further Alleviate Back Pain in a Lumbar Herniated Intervertebral Disc Patient
Sponsor: CynosureLutronic
A PHASE2/PHASE3 clinical study on Lumbar Herniated Intervertebral Disc, this trial is completed. The trial is conducted by CynosureLutronic and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Feb 2026 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 2 earlier versions
-
Apr 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed · Phase: PHASE3 → PHASE2_PHASE3
-
Jan 2017 — Apr 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CynosureLutronic
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.